CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 110 filers reported holding CUREVAC N V in Q4 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,954 | +22.1% | 2,190 | +86.2% | 0.00% | – |
| Q2 2023 | $12,248 | +52.6% | 1,176 | +2.0% | 0.00% | – |
| Q1 2023 | $8,028 | +14.7% | 1,153 | -4.9% | 0.00% | – |
| Q4 2022 | $7,000 | -36.4% | 1,213 | -10.0% | 0.00% | – |
| Q3 2022 | $11,000 | -42.1% | 1,348 | -6.9% | 0.00% | – |
| Q2 2022 | $19,000 | -40.6% | 1,448 | -11.0% | 0.00% | – |
| Q1 2022 | $32,000 | -38.5% | 1,627 | +3.6% | 0.00% | – |
| Q4 2021 | $52,000 | -50.0% | 1,570 | -17.4% | 0.00% | – |
| Q3 2021 | $104,000 | +36.8% | 1,900 | +82.7% | 0.00% | – |
| Q2 2021 | $76,000 | -24.0% | 1,040 | -5.2% | 0.00% | – |
| Q1 2021 | $100,000 | +127.3% | 1,097 | +100.9% | 0.00% | – |
| Q4 2020 | $44,000 | -2.2% | 546 | -44.1% | 0.00% | – |
| Q3 2020 | $45,000 | – | 976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $286,707,000 | 46.92% |
| Ally Bridge Group (NY) LLC | 110,000 | $10,061,000 | 1.93% |
| Parametrica Management Ltd | 44,695 | $3,968,000 | 1.91% |
| Renaissance Capital LLC | 123,983 | $11,339,000 | 1.68% |
| Samsara BioCapital, LLC | 95,318 | $8,718,000 | 1.61% |
| Ikarian Capital, LLC | 360,000 | $32,925,000 | 1.11% |
| SECTOR GAMMA AS | 25,000 | $2,287,000 | 0.42% |
| Fosun International Ltd | 50,000 | $4,438,000 | 0.35% |
| Ikarian Capital, LLC | 100,000 | $9,145,000 | 0.31% |
| Baillie Gifford | 5,830,101 | $533,221,000 | 0.30% |